Biotechnology Stocks I Performance Guide: Kymera Therapeutics, Inc. (KYMR)
KYMR has no dividends.
Table and Chart of KYMR Performance
See what a $1,000 investment in KYMR is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| KYMR Returns | |
|---|---|
| Start Date | Sep-30-2020 |
| Start Price | $32.31 |
| End Date | Jul-26-2024 |
| End Price | $44.54 |
| # Prices | 47 |
| Min Date | Oct-31-2023 |
| Min Price | $11.67 |
| Max Date | Dec-31-2021 |
| Max Price | $63.49 |
| Total Return | 37.85% |
| Annualized Return | 8.54% |
| Current Value of $1,000 Purchase | $1,379 |
| Number Returns | 1,081 |
| Average Return | -10.82% |
| Number Profitable Returns | 357 |
| Percent Profitable Returns | 33.02% |
| Number Unprofitable Returns | 724 |
| Percent Unprofitable Returns | 66.98% |
| Profitable to Unprofitable Returns Ratio | 0.49 |
| KYMR Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,702,220,000 |
| Beta | 2.222 | Price to Sales | 27.67 |
| Earnings per Share | $-2.5100 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 5.51 |
| PRICE DATA | |
| 52 Week High | $48.7 |
| 52 Week Low | $9.6 |
| Analyst Target Price | $51.43 |
| 50-Day Moving Average | $35.43 |
| 200-Day Moving Average | $30.63 |
| FINANCIAL DATA | |
| Revenue per Share | $1.291 |
| Revenue | $79,413,000 |
| Profit Margin | -194.7% |
| Return on Equity | -26.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
KYMR Compare Returns with S&P 500
KYMR Trendline Chart
KYMR Moving Average Chart
KYMR Stock Return Map - See Patterns of Gains and Losses
KYMR Stock Returns/Purchase Dates